AJP - Lung Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 292: L99-L106, 2007. First published September 15, 2006; doi:10.1152/ajplung.00269.2006
1040-0605/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/L99    most recent
00269.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldsmith, A. M.
Right arrow Articles by Bentley, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldsmith, A. M.
Right arrow Articles by Bentley, J. K.

Regulation of airway smooth muscle {alpha}-actin expression by glucocorticoids

Adam M. Goldsmith,1 Marc B. Hershenson,1,2 Miguel P. Wolbert,1 and J. Kelley Bentley1

Departments of 1Pediatrics and Communicable Diseases and 2Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan

Submitted 17 July 2006 ; accepted in final form 9 September 2006

Airway smooth muscle hypertrophy appears to be present in severe asthma. However, the effect of corticosteroids on airway smooth muscle cell size or contractile protein expression has not been studied. We examined the effects of dexamethasone, fluticasone, and salmeterol on contractile protein expression in transforming growth factor (TGF)-beta-treated primary bronchial smooth muscle cells. Dexamethasone and fluticasone, but not salmeterol, each reduced expression of {alpha}-smooth muscle actin and the short isoform of myosin light chain kinase. Steady-state {alpha}-actin mRNA level and stability were unchanged, consistent with posttranscriptional control. Fluticasone significantly decreased {alpha}-actin protein synthesis following treatment with the transcriptional inhibitor actinomycin D, indicative of an inhibitory effect on mRNA translation. Fluticasone also significantly increased {alpha}-actin protein turnover. Finally, fluticasone reduced TGF-beta-induced incorporation of {alpha}-actin into filamentous actin, cell length, and cell shortening in response to ACh and KCl. We conclude that glucocorticoids reduce human airway smooth muscle {alpha}-smooth muscle actin expression and incorporation into contractile filaments, as well as contractile function, in part by attenuation of mRNA translation and enhancement of protein degradation.

corticosteroids; fluticasone; hypertrophy; salmeterol; transforming growth factor-beta



Address for reprint requests and other correspondence: J. Kelley Bentley, Univ. of Michigan, 1150 W. Medical Center Dr., Rm. 3570, MSRBII, Box 0688, Ann Arbor, MI 48109-0688 (e-mail: kbentley{at}umich.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Hu, S. Fatma, J. Cao, J. S. Grunstein, G. Nino, Y. Grumbach, and M. M. Grunstein
Th2 cytokine-induced upregulation of 11{beta}-hydroxysteroid dehydrogenase-1 facilitates glucocorticoid suppression of proasthmatic airway smooth muscle function
Am J Physiol Lung Cell Mol Physiol, May 1, 2009; 296(5): L790 - L803.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. G. Woodruff
Gene Expression in Asthmatic Airway Smooth Muscle
Proceedings of the ATS, January 1, 2008; 5(1): 113 - 118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.